Search

Your search keyword '"Epidemiologic Methods"' showing total 676 results

Search Constraints

Start Over You searched for: Descriptor "Epidemiologic Methods" Remove constraint Descriptor: "Epidemiologic Methods"
676 results on '"Epidemiologic Methods"'

Search Results

151. Modeling Seasonal and Spatiotemporal Variation: The Example of Respiratory Prescribing.

152. Is there any alternative to traditional food frequency questionnaire for evaluating habitual dietary intake?

153. Choice of relative or cause-specific approach to cancer survival analysis impacts estimates differentially by cancer type, population, and application: evidence from a Canadian population-based cohort study.

154. Bayesian Estimation of Pneumonia Etiology: Epidemiologic Considerations and Applications to the Pneumonia Etiology Research for Child Health Study.

155. Prevalence and Predictors of Diastolic Dysfunction According to Different Classification Criteria: The Coronary Artery Risk Development in Young in Adults Study.

156. Comparative effects of the restriction method in two large observational studies of body mass index and mortality among adults.

157. Number needed to treat (NNT) in clinical literature: an appraisal.

158. REPRODUCIBILITY AND VALIDITY OF A SEMIQUANTITATIVE FOOD FREQUENCY QUESTIONNAIRE.

159. The Case-Crossover Design: A Method for Studying Transient Effects on the Risk of Acute Events.

160. Exposure Opportunity: The Advantages of Including Men in Analyses of Female-Related Risk Factors.

161. The "Dry-Run" Analysis: A Method for Evaluating Risk Scores for Confounding Control.

162. Sharp bounds on sufficient-cause interactions under the assumption of no redundancy.

163. Evidence for Detection Bias by Medication Use in a Cohort Study of Breast Cancer Survivors.

164. Measuring the Association Between Body Mass Index and All-Cause Mortality in the Presence of Missing Data: Analyses From the Scottish National Diabetes Register.

165. Power and Sample Size Calculations in Case-Control Studies of Gene- Environment Interactions: Comments on Different Approaches.

166. Conducting Privacy-Preserving Multivariable Propensity Score Analysis When Patient Covariate Information Is Stored in Separate Locations.

167. Benchmarking prescription drug access patterns in pharmaceutical claims: a method for identifying high and potentially harmful opioid use in Australia and Canada?

168. An empirical method to cluster objective nebulizer adherence data among adults with cystic fibrosis.

169. Lifestyle factors and prostate-specific antigen (PSA) testing in UK Biobank: Implications for epidemiological research.

171. Observational studies and the difficult quest for causality: lessons from vaccine effectiveness and impact studies.

172. Controlling for Informed Presence Bias Due to the Number of Health Encounters in an Electronic Health Record.

173. Persistent User Bias in Case-Crossover Studies in Pharmacoepidemiology.

174. Adjusting for overdispersion in piecewise exponential regression models to estimate excess mortality rate in population-based research.

175. Predictor characteristics necessary for building a clinically useful risk prediction model: a simulation study.

176. Instrumental-Variables Simultaneous Equations Model of Physical Activity and Body Mass Index.

177. Invited Commentary: Harnessing Housing Natural Experiments Is Important, but Beware Differential Misclassification of Difference in Difference.

178. An introduction to the partial least squares approach to structural equation modelling: a method for exploratory psychiatric research.

179. Transcultural adaptation of the Breast Cancer Awareness Measure.

180. Theoretical Basis of the Test-Negative Study Design for Assessment of Influenza Vaccine Effectiveness.

181. Comparison of Statistical Approaches for Dealing With Immortal Time Bias in Drug Effectiveness Studies.

182. An Illustration of Inverse Probability Weighting to Estimate Policy-Relevant Causal Effects.

183. Use of the "Exposome" in the Practice of Epidemiology: A Primer on -Omic Technologies.

184. Point: Immortal Time Bias—What Are the Determinants of Its Magnitude?

185. Study designs: Part 2 – Descriptive studies.

186. Study designs: Part 1 - An overview and classification.

187. Comparison of Calipers for Matching on the Disease Risk Score.

188. 输卵管性不孕的流行病学及病因.

189. Incident Ischemic Heart Disease After Long-Term Occupational Exposure to Fine Particulate Matter: Accounting for 2 Forms of Survivor Bias.

190. Accurate reporting of adherence to inhaled therapies in adults with cystic fibrosis: methods to calculate "normative adherence".

191. Quantity Versus Quality: A Survey Experiment to Improve the Network Scale-up Method.

192. Straight Metalworking Fluids and All-Cause and Cardiovascular Mortality Analyzed by Using G-Estimation of an Accelerated Failure Time Model With Quantitative Exposure: Methods and Interpretations.

193. Incorporating Transmission Into Causal Models of Infectious Diseases for Improved Understanding of the Effect and Impact of Risk Factors.

194. Reporting of Rehabilitation Intervention for Low Back Pain in Randomized Controlled Trials: Is the Treatment Fully Replicable?

195. Ancient Disease, Modern Epidemiology: A Century of Progress in Understanding and Fighting Tuberculosis.

196. Epidemiology and the Tobacco Epidemic: How Research on Tobacco and Health Shaped Epidemiology.

197. Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques.

198. Incorrect inference in prevalence trend analysis due to misuse of the odds ratio.

199. Systematic review of the cardiovascular effects of occupational noise.

200. How to Perform and Interpret a Network Meta-Analysis for Indirect and Mixed Comparisons: Key Methodological Strategies.

Catalog

Books, media, physical & digital resources